PRODUCT NEWS

ELITechGroup launches CE-IVDR certified GI Bacterial PLUS ELITe MGB® Kit and expands in vitro diagnostic portfolio

  • ELITechGroup launches their first kit of the Gastrointestinal assay panel targeting bacterial pathogens.
  • ELITechGroup is planning to launch three additional kits covering the full range of gastrointestinal infections within the next quarter.

In a significant move towards advancing global diagnostic capabilities, ELITechGroup proudly announces the introduction of the GI Bacterial PLUS ELITe MGB® Kit, a robust addition to its diagnostic portfolio. Tailored specifically for diagnosing gastrointestinal bacterial infections, the in vitro assay exclusively targets major bacterial pathogens including Campylobacter spp., Clostridium difficile, Salmonella spp., Shigella spp., and Yersinia enterocolitica. These pathogens are widely acknowledged as significant contributors to global food and waterborne, as well as hospital-acquired, gastrointestinal infections.

The entire process underlying the GI Bacterial PLUS ELITe MGB® Kit, from extraction to result interpretation, has achieved CE-IVDR certification, underscoring ELITechGroup’s unwavering commitment to the highest standards of quality. Fully validated with ELITe InGenius and ELITe BeGenius sample-to-result instruments, the kit is designed to deliver precision diagnostics of human stool specimens.

Aligning with the company’s dedication to precision molecular diagnostics, ELITechGroup is set to launch three more in vitro diagnostic kits for Gastrointestinal Infections, covering parasitic and viral pathogens- GI Parasitic PLUS ELITe MGB® Kit, GI Viral PLUS ELITe MGB® Kit, and GI Norovirus PLUS ELITe MGB® Kit.

These new launches aim to provide a comprehensive solution for the management of life-threatening gastrointestinal infections marking a pivotal milestone in ELITechGroup’s mission to provide state-of-the-art diagnostic solutions.

About ELITechGroup

ELITechGroup is an integrated in-vitro diagnostics company that serves hospitals and diagnostic laboratories in more than 100 countries. The company develops, manufactures, and markets a wide range of diagnostic products and solutions – instruments, reagents, and software.

ELITech Molecular Diagnostics (MDx), one of the four business units of ELITechGroup, serves the needs of clinical and research laboratories by offering a wide range of molecular diagnostic products, including nearly 60 CE-IVD assays and instruments as well as software applications.

Latest news

NEWSROOM

ELITechGroup Announces Regulatory Approval of its Blood Borne Virus Panel in Japan

ELITechGroup’s blood-borne virus (BBV) panel received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) The ELITe BBV panel was launched in 2022 and comprises three quantitative IVD assays targeting Human Immunodeficiency virus-1 (HIV-1), Human Hepatitis B Virus (HBV), and Human Hepatitis C Virus (HCV) Turin, June 13, 2024: ELITechGroup…

ELITechGroup achieves a new CE-IVDR Certification

ELITechGroup continues to expand its portfolio of IVDR-certified PCR assays to support European diagnostic laboratories The newly obtained IVDR certificate will expedite the transition to IVDR for quantitative Class C infectious diseases assays The company is fully committed to delivering its entire portfolio of nearly 60 molecular assays as IVDR…

ELITechGroup Launches Second IVDR Certified Gastrointestinal Infection Assay: GI Parasitic PLUS ELITe MGB® Kit 

ELITechGroup launches their second kit of the Gastrointestinal infection assay panel targeting parasitic pathogens.  The ELITe MGB Gastrointestinal assays are IVDR-certified in combination with InGenius and BeGenius, fully automated samples-to-results instruments.  The company will shortly launch two more gastrointestinal assay infection panels targeting viral pathogens and Norovirus.   ELITechGroup announces the…

Let us help you

For general inquiries, please use the links to the right. The Contact link leads to a brief online form, and the Support link offers general phone and email information. Someone will be in touch with you soon.